Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Red blood cell traits

IKZF1 · rs12718598

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−18, with 5 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 62,553 European ancestry individuals, 9,308 South Asian ancestry individuals; replicated in 63,506 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.204 lower (95% confidence interval 0.15-0.26); p = 2 × 10−13.

How common The T allele had a frequency of about 51% in the people studied.

Where it sits Chromosome 7, band 7p12.2 — in an intron of IKZF1.

How common each version is

CT
Korean KRGDB
C 39.8% · T 60.2%
Korean Korea4K
C 41.6% · T 58.4%
Korean Korea1K
C 42.0% · T 58.0%
Japanese ToMMo
C 36.8% · T 63.2%
World gnomAD
C 49.8% · T 50.2%
World 1000 Genomes
C 50.1% · T 49.9%
World TOPMed
C 51.4% · T 48.6%

By ancestry gnomAD

East Asian
C 40.6% · T 59.4%
European (non-Finnish)
C 48.7% · T 51.3%
African / African American
C 51.5% · T 48.5%
South Asian
C 50.5% · T 49.5%
Admixed American (Latino)
C 59.1% · T 40.9%
Middle Eastern
C 53.4% · T 46.6%
Finnish
C 38.9% · T 61.1%
Ashkenazi Jewish
C 55.2% · T 44.8%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Red blood cell traits. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Red blood cell traits. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Red blood cell traits. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Red blood cell traits (rs12718598). MyGeneLog™. https://www.mygenelog.com/variants/rs12718598

← See all variants